| Meta | Value |
|---|---|
| Rating | Cautiously Bullish |
| Target Price | RMB 30–42 (base-case fair value range, on a fully diluted H-share basis) |
| Current Price | RMB 26.89 (close on 2026-10-28, price anchor of this report) |
| Margin of Safety | +11.6% (base-case fair value floor of RMB 30 vs. current price of RMB 26.89) |
| Market Cap | Approx. RMB 54.8 billion (2,038.6 million total shares) |
| Time Horizon | 12 months |
| Sector | Lithium battery electrolyte / lithium hexafluorophosphate (highly cyclical chemical materials) |
Tinci Materials is the undisputed global electrolyte leader; 2026 is a peak earnings year (H1 net profit attributable to parent of RMB 2.861 billion, +968% YoY), yet the stock is down 44% YTD and near its 52-week low — the market is pricing in advance the "2026–2027 LiPF6 supply release + H-share dilution." Based on a normalized cyclical framework, the current price of RMB 26.89 implies normalized net profit attributable to parent of only about RMB 3.7–4.6 billion and a LiPF6 midpoint of RMB 90,000–105,000/ton, below the actual run-rate of about RMB 4.8 billion annualized this quarter; structural volume growth in energy storage is almost entirely unpriced — undervalued on a cyclical basis. Key constraints: LiPF6 prices have already fallen from the December 2025 peak of about RMB 180,000/ton to RMB 106,000–120,000; new industry supply is rolled out in stages through H2 2026–2027, so the risk of YoY profit decline in 2027 is real; the H-share issuance (Q4) and RMB 10.736 billion in accounts receivable are two near-term overhangs. We are cautiously bullish, with the Q3 report (10-31), H-share pricing, and the Q4 LiPF6 price path as the nearest validation points.
The core evidence of leadership and cost advantage is "profitability at the trough": in 2024, when the average LiPF6 price was about RMB 70,000/ton and the whole industry was loss-making, Tinci still earned net profit attributable to parent of RMB 484 million (non-recurring: RMB 382 million); in 2026H1, lithium battery materials gross margin was 33.72%, well above Capchem's battery chemicals margin of 15.32%. The liquid LiPF6 phase-transfer process is the technical source of the cost advantage (prospectus basis: unit capex for liquid LiPF6 is about 40% of the solid-state process). A negative development to acknowledge: CATL's 2026–2028 long-term contract for a cumulative 770,000 tons of electrolyte has been awarded to Capchem (300,000 tons) and Yongtai Technology (470,000 tons) (Cailian Press, 2026-06); Tinci has switched to spot supply for CATL — leadership remains solid, but "absolute share" has entered a redistribution phase.
Volume growth is structural: the company has locked in over 3.4 million tons via long-term contracts (Chuneng 101 / REPT ≥80 / Gotion 87 / CALB 72.5, per association reposts pending verification); 2026 shipments are expected at 1.0–1.05 million tons (+30%–45% YoY, base of 720,000–770,000 tons in 2025). But "volume-locked, price-open" means full exposure on price — 2026Q2 already provided the test: with shipments still growing, quarterly net profit attributable to parent fell ~27% QoQ from Q1's RMB 1.654 billion to RMB 1.207 billion (driven by the decline in average LiPF6 prices). The volume cushion exists; the hedge does not. Moreover, if 2026Q3 shipments turn negative QoQ or the storage production share trend falls below 30%, this thesis is weakened.
The current price requires the company to "deliver normalized earnings of about RMB 4 billion," whereas the reality is a single-quarter annualized run-rate of RMB 4.8 billion plus 1.05 million tons of capacity and locked contract volumes: the market's pessimistic pricing (2027 supply release) is directionally grounded but excessive in magnitude. The key premise of this judgment is the exit multiple anchor (comparables average 12.78x 2026E; 12–14x used after excluding peak earnings) — if the market persists in assigning single-digit forward PE to cyclical chemicals, the discount may never close; this is the multiple-assumption risk.
This report's sensitivity framework is uniform: every RMB 10,000/ton decline in LiPF6 impacts annualized net profit by ~RMB 0.9–1.3 billion (1.05 million tons shipped × RMB 900–1,300 per ton per RMB 10,000; sensitivity narrows non-linearly as prices fall — at ~RMB 70,000/ton in 2024, per-ton non-recurring profit was still positive at RMB 763, and linear extrapolation to deep troughs would produce factually incorrect negative profits). If LiPF6 falls to RMB 60,000–70,000/ton in 2027, net profit attributable to parent would drop to RMB 0.8–1.3 billion (calibrated to 2024 actual of RMB 484 million × ~2x current volume). Bear-case fair value: RMB 15–19 (trough PB 1.6–2.0x × diluted book value per share).
The H-share issuance is Q4's single biggest event: a discount ≤10% and actual size clearly below the cap would be a positive catalyst realized; a deep discount (>15%) or full-cap issuance would directly lower the A-share valuation anchor (on full dilution, this report's EPV is ~RMB 20/share). The receivables issue cuts both ways: on one hand, OCF severely diverges from profit and absolute receivables are huge; on the other, the aging profile is young, dominated by bank acceptance bills, and the receivables/annualized revenue ratio actually fell from 41.3% to 36.5% (revenue growth of 109% outpacing receivables growth of 56%). In a cyclical downturn, if downstream funding stress transmits along the supply chain (a risk the company itself lists in its interim report), cash conversion and provisioning discipline will be tested; receivables aging and bill discounting scale must be tracked quarterly.
| Metric | 2023FY | 2024FY | 2025FY | 2026Q1 | 2026H1 (latest) |
|---|---|---|---|---|---|
| Revenue (RMB 100M) | 154.05 | 125.18 | 166.50 | 66.73 | 147.10 |
| Net profit attributable to parent (RMB 100M) | 18.91 | 4.84 | 13.62 | 16.54 | 28.61 |
| Non-recurring net profit (RMB 100M) | 18.24 | 3.82 | 13.60 | 15.60 | 28.07 |
| Gross margin | 25.92% | 18.89% | 22.24% | 38.65% | 33.55% |
| Net margin | 12.28% | 3.87% | 8.18% | 24.79% | 19.45% |
| Operating cash flow (RMB 100M) | 22.74 | 8.82 | 11.82 | — (unverified) | 3.97 |
| Free cash flow (RMB 100M) | -8.28 | 1.10 | 5.23 | — | -1.68 |
| Cash + cash-like assets (period-end, RMB 100M) | — | — | 24.03 | — | 21.97 |
| Interest-bearing debt (period-end, RMB 100M) | — | 64.26 (incl. CB 34.13) | 29.21 | — | 29.82 |
| Debt-to-asset ratio (period-end) | 52.94% | 44.37% | 33.02% | — | 36.22% |
Note: Net interest-bearing debt at end-2026H1 was ~RMB 785 million (cash-like 21.97 − interest-bearing debt 29.82); leverage is extremely low relative to 2026 annualized EBITDA (on the order of RMB 8–9 billion); after the H-share raise of US$400–500 million lands, the company would turn into a net cash position of roughly +RMB 2.1–2.8 billion. 2024 interest-bearing debt included RMB 3.411 billion of convertible bonds (fully converted within 2025; debt-to-equity conversion of RMB 3.503 billion).
Drivers of metric changes (items with YoY ≥ ±20%, with company explanations):
H1 revenue of RMB 14.710 billion (+109.28%), net profit attributable to parent RMB 2.861 billion (+967.91%), non-recurring RMB 2.807 billion (+1096.69%) — half-year profit has already reached half of the previous cycle's peak year (2022: RMB 5.714 billion). Three structural readings: ① quarterly cadence: Q1 net profit attributable RMB 1.654 billion (gross margin 38.65%, including low-cost lithium carbonate inventory gains), falling to ~RMB 1.207 billion in Q2 (~−27% QoQ); the company attributes this to "the phase adjustment in LiPF6 prices driving a sequential gross margin decline" (2026-09-17 collective reception minutes); ② quality of volume: electrolyte volume 440,000 tons (+41%), storage electrolyte +100%+, overseas sales +126% (low base; overseas revenue share only ~3%); ③ reconciliation vs. expectations: H1 net profit represents 46% of 2026 consensus of RMB 6.22 billion — normal progress, but H2 needs sequential volume growth (Q2 annualized only ~RMB 4.8 billion) to meet consensus — the debate hinges on the Q4 LiPF6 price path. Cash flow is the biggest blemish: OCF only RMB 397 million, cash-to-profit ratio 0.14, receivables up RMB 3.86 billion in six months. Overall: the volume logic is being delivered, the price elasticity has passed its peak, consistent with a "mid-to-upper range cyclical recovery" positioning.
Business model in brief: Asset-heavy, integrated fine chemicals — self-produced LiPF6 (solid-equivalent capacity ~145,000 tons, 99.3% self-supplied), LiFSI (30,000 tons, 97%+ self-supplied), additives and high-purity lithium carbonate (100% self-supplied), formulated into electrolyte for sale (annual capacity 1.05 million tons), with battery makers under long-term contracts as the downstream; plus a personal-care materials cash cow and LFP cathode (in ramp-up). Revenue has no subscription attribute and fluctuates with the LiPF6/lithium carbonate cycle; the company is essentially "the lowest-cost price taker" — no pricing power, but positioned at the industry's lowest cost curve.
Cash content of earnings test: OCF/net profit attributable was 1.20 in 2023, 1.82 in 2024, 0.87 in 2025, and 0.14 in 2026H1; FCF/net profit attributable was -0.44, 0.23, 0.38, and -0.06 respectively. Cash conversion was good at the trough (profits compressed to true levels), but it drops sharply in peak years — of the RMB 2.861 billion in book profit in 2026H1, only RMB 397 million was collected in cash, with the gap piling up in receivables (+RMB 3.86 billion) and inventory. The company's "bills not discounted" explanation is partially corroborated by receivables financing (RMB 1.409 billion) and endorsed-not-derecognized bank bills (RMB 7.018 billion), but a cash-to-profit ratio of 0.14 remains a red flag requiring continuous tracking. Recurring earnings: 2026H1 non-recurring RMB 2.807 billion vs. attributable RMB 2.861 billion — a gap of only 2%, with minimal one-off impact (impairments already provisioned in the period).
Return on capital: ROIC ~7.2% (2025, estimated), ~3.2% at the 2024 trough — both below the 15% "true moat" line, but this must be read cyclically: 2026 annualized ROIC will rebound significantly (half-year ROE 15.0%, ~30% annualized); the through-cycle midpoint depends on normalized earnings (~RMB 4.8 billion implies ROIC of ~15–18%). Capital returns average above the industry across the cycle but are highly volatile.
Capex quality: CapEx/depreciation was 0.80 in 2024 and 0.62 in 2025 — the previous expansion peak (2023 CapEx of RMB 3.025 billion) has passed, and recent investment is below depreciation; no maintenance/growth split disclosed, but with construction-in-progress down 26.7% vs. year-start and fundraising projects progressively transferred to fixed assets, the company appears to be in a harvest phase. Note that the 2027 year-end electrolyte capacity plan is 1.8 million tons (vs. 1.05 million currently) plus US/Morocco projects, meaning CapEx will restart from 2027 and free cash flow will come under pressure again.
Moat and red flags: Moat = liquid LiPF6 process cost advantage + full-chain self-supply + long-term customer contracts. Red flags: ① largest customer accounted for 36.10% of revenue (2025); in 2026H1, ~42.9% (prospectus basis); ② the large divergence between 2026H1 profit surge and cash flow (see above); ③ the cathode materials business only turned monthly profitable in 2026H1, and iron phosphate inventory has had RMB 77.7188 million in price-decline provisions.
Words-vs-deeds consistency: partially fulfilled, pragmatic overall but with a record of delays. Four promise-vs-delivery comparisons: ① 2021/2022 equity incentive performance targets—missed; multiple rounds of buyback and cancellation of restricted shares (2024-05, 2025-02), not fulfilled; ② 2022 convertible bond fundraising projects (20,000 t LiFSI, 62,000 t electrolyte base materials, 41,000 t lithium battery materials)—LiFSI "profitability below expectations", the 62,000 t project "low operating rate", the 41,000 t project delayed three times and repurposed in July 2026, partially not fulfilled (multiple delays/changes); ③ 2023–2025 shareholder return plan—2024 payout ratio 39.38%, 2025 cash dividend RMB 710 million (including special dividend, payout ratio 52.15%), plus another interim dividend of RMB 203 million in 2026, fulfilled and enhanced; ④ 2022 GDR plan terminated in April 2025, pivoted to an H-share listing which passed the hearing in 2026, progressing after plan change. Overall verdict: operating promises discounted, return promises honored.
Shareholder friendliness: neutral leaning friendly. Payout ratio rising consecutively (39% → 52% + interim dividend), RMB 122 million buyback in 2025; but the RMB 3.4 billion convertible bond dilutes about 6% upon conversion, the H-share offering is in the pipeline (6–17% dilution), and during 2026 as the stock fell from RMB 40 to RMB 27, investors repeatedly and publicly urged buybacks, with the company only responding "will disclose if any" and taking no substantive price-supporting action.
Risk signals: Actual controller Xu Jinfu holds 34.27%, with zero increases/decreases during the reporting period; directors/senior management (Xu Sanshan, Gu Bin, Shi Litao) completed their March 2026 selling plans (approximately 680,000 shares in total, <0.04% of total share capital—small magnitude); the company itself disclosed "derivative investments for speculative purposes" (2025 P&L -RMB 1.922 million, 2026H1 +RMB 7.326 million—small amounts but a mediocre governance signal); information disclosure rated Grade A by the Shenzhen Stock Exchange for five consecutive years.
| Segment (2026H1) | Revenue share | Gross margin | GM YoY | Revenue YoY | One-line business logic |
|---|---|---|---|---|---|
| Lithium-ion battery materials (electrolyte + 6F/LiFSI + cathode + adhesives) | 93.05% | 33.72% | +16.67pp | +117.20% | Integrated manufacturing, prices fluctuate with the 6F/lithium carbonate cycle |
| Daily-use chemicals & specialty chemicals | 4.67% | 27.50% | -2.77pp | +11.78% | Stable cash cow, tied to multinational personal-care clients |
| Others (resource recycling/lithium carbonate, etc.) | 2.28% | 39.00% | — | +197.19% | Lithium carbonate delivery and recycling, benefiting from the lithium price rebound |
Core profit segment: Lithium battery materials—93% revenue share × 33.72% gross margin, contributing about 96% of gross profit; the company is effectively a single-business company, with the daily-chemicals and other segments too small to change its cyclical nature. FY2025 basis: lithium battery materials 90.39% revenue share / 21.27% GM, daily chemicals 7.72% / 29.90%, others 1.89% / 37.45%.
Gross margin structure differences: highest (others 39.00%) vs lowest (daily chemicals 27.50%), a gap of 11.5pp—the "others" segment is lithium carbonate recycling and delivery, directly benefiting in 2026H1 from inventory gains as lithium prices rebounded from lows, a cyclical rather than structural high margin; the 2.77pp YoY decline in daily chemicals reflects competition in personal-care ingredients. The difference that truly matters is intra-segment cyclical beta: lithium battery materials' GM swung 16.67pp within a year while daily chemicals only 2.77pp—nearly all the cyclical elasticity comes from the core business.
Accounting red flags:
Cross-period consistency:
Current market data (2026-10-28 close): share price RMB 26.89, market cap RMB 54.8 billion. PE(TTM) 13.9x (TTM attributable profit RMB 3.955 billion; 1/3/5-year percentiles 0%/4%/7%—earnings are in a cyclical upswing, percentiles are for reference only, not a headline cheapness signal); PB 2.70x (roughly 12% 5-year percentile; denominator includes a one-off boost from ~RMB 3.4 billion of convertible conversion in 2025, reducing cross-period comparability); 2026E consensus PE 8.8x / 2027E 7.5x.
| Peer comparison | PE(TTM) | PB | 2026 9M attributable growth | Characteristics |
|---|---|---|---|---|
| Tinci Materials | 13.9x | 2.70 | H1 +968% | Integrated leader, largest volume and highest elasticity |
| Capchem | 20.2x | 3.32 | +106% | Platform type (fluorochemicals/electronic chemicals hedge the cycle) |
| Do-Fluoride | 37.9x | 3.14 | +659% | Pure 6F elasticity play, TTM includes trough base—inflated |
| Tianji Shares | 12.4x | 1.60 | +371% | Second-tier 6F + ST governance discount |
Market-implied expectations (headline): Back-solving at a 12–15x mid-cycle multiple, the RMB 54.8 billion market cap implies normalized attributable profit of ~RMB 3.7–4.6 billion and a 6F mid-cycle price of RMB 90,000–105,000/t—the current price requires the company to return to a mid-cycle "6F at 90,000–105,000" level, whereas reality is 6F at 106,000–120,000, ~1 week of inventory, 89% utilization, and ~RMB 4.8 billion annualized quarterly profit. The market has largely priced in the pessimistic scenario of 2027 supply release (stock -44% YTD, consensus cut 9.7% over the past 90 days) but has paid almost nothing for structural volume growth in energy storage.
Three-tier value (EPV): Based on sustainable FCFE (normalized attributable profit midpoint ~RMB 4.8 billion: RMB 4,000–5,000 net profit per tonne × 1.05 million tonnes in operation at full run-rate; bridge: profit 48 + D&A 13 − maintenance CapEx 9 − working capital increase 3 ≈ RMB 4.9 billion/year ≈ RMB 2.4/share; cost of equity 10%, using only in-operation assets—the 2027 plan of 1.8 million tonnes and overseas projects excluded from EPV), EPV is ~RMB 24.0/share, about 89% of the current price; the growth option (storage volume + overseas + solid-state) residual is ~RMB 2.85, about 10.7% of the current price—the market pays almost only for zero-growth mid-cycle earnings. Asset value (book value per share RMB 9.95, 2026-06-30) provides an independent floor reference. Note: after maximum H-share dilution, EPV falls to ~RMB 20/share.
Three scenarios and odds (fair ranges are on a conservative post-max-H-dilution basis; probabilities are this report's judgment):
| Scenario | Probability | Fair range | vs current price | Key swing factors |
|---|---|---|---|---|
| Bear | 28% | RMB 15–19 | median -36.8% | 6F falls to 60,000–70,000 in 2027 + deep-discount/max-dilution H-share issuance; trough PB 1.6–2.0x × diluted book value as primary anchor (the 2024 trough market traded at ~2x PB) |
| Base | 52% | RMB 30–42 | median +33.9% | 6F oscillates at 90,000–110,000 midpoint + 2027 shipments ~1.2 million tonnes (+15–20%); 2027E attributable profit RMB 5.5–6.8 billion × 12–14x (anchor: comparable 2026E average 12.78x, denominator de-peaked; independent of the company's current multiple) |
| Bull | 20% | RMB 52–70 | median +126.9% | Storage/AI upside keeps 6F tight through 2028, price 120,000+; attributable profit RMB 8.5–9.5 billion × 15–18x |
The current price of RMB 26.89 sits below the lower edge of the base range (11.6% below the base floor); the odds distribution favors an asymmetric long structure with insufficient downside protection but ample upside elasticity; probability-weighted fair value ~RMB 35.7 (about +33%).
Exit multiple anchoring rationale: Base scenario 12–14x—the floor anchors to the comparable 2026E average of 12.78x (iFinD via Essence Securities: Capchem/Do-Fluoride/Hunan Yuneng); the ceiling references a ~30% discount to platform-type Capchem's TTM 20.2x (Tinci has higher single-business cyclical purity); this report uses "denominator de-peaked (2027E RMB 5.5–6.8 billion already normalized at a 90,000–110,000 6F midpoint) + numerator at slightly below peer midpoint" to avoid circular reasoning from validating the current price with the current multiple. Sensitivity: holding base earnings constant, exit multiple ±5x maps to roughly RMB 25–49.
Own earnings forecast (side-by-side: management guidance, sell-side consensus, this report):
| Period | Revenue | Attributable net profit | Key drivers | Management guidance | Consensus |
|---|---|---|---|---|---|
| 2026E | RMB 30.0–31.5 billion | RMB 5.8–6.3 billion | Shipments 1.0–1.05 million tonnes, H2 6F avg price 110,000–120,000, RMB 4,800–5,500 net profit/tonne | Full production and sales, storage growth above power, volume-locked not price-locked (no figures given) | RMB 6.22 billion |
| 2027E | RMB 33.0–36.5 billion | RMB 5.5–7.0 billion | Shipments ~1.2 million tonnes, 6F midpoint 90,000–110,000, RMB 4,200–5,200/tonne, iron phosphate turning profitable by RMB 200–500 million | No profit guidance; capacity plan of 1.8 million tonnes by end-2027 | RMB 7.27 billion |
Our 2027 estimate is 4%–24% below consensus; the point of divergence is the 6F midpoint (consensus implies a sustained 110,000+; this report assumes oscillation at 90,000–110,000).
Conclusion: undervalued; judge quality and price separately—quality is a top-tier asset within a cyclical industry (left of the cost curve + full utilization + long-term contracts); on price, the current level fully prices the pessimistic scenario and pays nothing for volume growth; target price RMB 30–42 (= base-case fair range), safety margin +11.6% (base-floor basis). This is cyclical-stock undervaluation, not growth-stock undervaluation; the holding experience will swing sharply with weekly 6F quotes; if the market persistently assigns single-digit forward PEs to cyclical chemicals, the discount may never close.
1. Market size. By shipment volume: 2025 global electrolyte shipments of 2.402 million tonnes (+44.5% YoY, EVTank), of which China 2.235 million tonnes, 93% of global; 2026H1 global output ~1.48 million tonnes (+47.2%). At October 2026 prices, value terms ~RMB 53–60 billion/year (not an institutional estimate; this report's calculation); LiPF6 demand in 2026 ~354,000 tonnes (Soochow estimate) × ~RMB 110,000/t ≈ RMB 39 billion/year. Growth forecasts: 2025–2030 global electrolyte shipment CAGR ~22.2% (to ~5.47 million tonnes, CIC, the agency engaged for Tinci's H-share prospectus—broadly consistent after cross-checking against EVTank growth rates, direction credible), 6F CAGR 19.1%, LiFSI CAGR 40.3%. Downstream: global lithium batteries ~2,257GWh in 2025 → ~6,284GWh in 2030 (CIC); energy storage is the primary engine—global ESS batteries 551GWh in 2025 (+70%) → 2026E 773GWh (+40%), power ~1,710GWh in 2026E (+20%) (Soochow). Nature of the demand inflection: the storage boom is aggregate downstream volume growth (GWh-scale ramp), with per-GWh electrolyte consumption essentially unchanged (~900–1,000 tonnes); only the VC additive intensity rises with the storage share (storage ≥3% vs power 1–3%)—this does not constitute a structural inflection of "order-of-magnitude jump in unit consumption"; the industry's valuation paradigm remains cyclical rather than growth, and this report primarily applies a cyclical analytical framework (Chapter XI).
2. Value chain and profit distribution. Upstream: lithium carbonate (GFEX main contract closed 2026-10-28 at RMB 93,300/t, -28% YTD) + anhydrous HF/phosphorus pentachloride + solvents (Shida Shenghua holds >40% of global high-end carbonate esters) + VC additive (surging to ~RMB 230,000/t since July 2026 due to shortage, with hazardous-chemical approvals constraining new capacity). Midstream: LiPF6 (largest electrolyte cost item, ~60%) → electrolyte formulation; global effective 6F capacity ~390,000 tonnes (China 371,000 tonnes), CR3 >70%, top players running at 85–100%. Downstream: highly concentrated cell makers (CATL and BYD self-supply account for 13.4% of China), extracting price concessions via volume and long-term contracts. Gross margin accrues to the cost-advantaged 6F/additive links: 2026H1 Tinci lithium battery materials GM 33.72% vs Capchem battery chemicals 15.32%, Tianji 6F 18.12%, industry 6F average 23.29% (Longzhong)—pure electrolyte formulation is the lowest-barrier link (industry GM once as low as 7.56% in 2024). Tinci sits in an integrated midstream position: 6F self-supply 99.3%, LiFSI 97.1%, DTD 80.8%, high-purity lithium carbonate 100% (CIC, as of 2026-06-30)—low passive exposure to upstream pricing, weak bargaining power downstream (prices follow the market).
3. Supply-demand and competitive structure. Nominal oversupply coexists with effective tight balance: 2026 global nominal electrolyte capacity ~3.4 million tonnes vs output ~3 million tonnes (Xinlidian); 6F 2026E effective supply 397,000 tonnes vs demand 354,000 tonnes, utilization 89% (Soochow), industry inventory only ~1 week. Concentration: China electrolyte CR5 ~69.5% (2025, EVTank: Tinci 32.2%, BYD self-supply 13.4%, Capchem 13.0%, Kunlun New Materials 5.6%, Zhuhai Saiwei 5.3%); global CR5 ~75.5%, Tinci first at 36.0% (CIC)—the two bases shown side-by-side; the ~3.8pp gap mainly reflects statistical boundaries (whether self-supply and exports are included); this report does not adopt either extreme alone. Entry barriers: highest at the 6F link (liquid-phase process, hazardous-chemical approvals, dual energy-consumption control—new capacity requires comprehensive energy ≤1.8 t coal equivalent/t, 12–18 month build cycle); electrolyte formulation itself has low barriers. Competitive intensity: after the brutal price war of 2023–2025H1, the industry moved from losses to recovery; currently top players are defending prices while competition shifts to locking orders via long-term contracts and fighting for share—CATL from 2026 is diversifying 770,000 tonnes of orders to Yonfu/Capchem (customer rebalancing), while Tinci hedges by binding second-tier cell makers with ~3.4 million tonnes of long-term contracts. Substitution threat: solid-state batteries could replace liquid electrolyte in the long run, but all-solid-state is expected in small-volume vehicle deployment in 2027 and scale by 2030; CIC forecasts the global solid electrolyte market at only ~RMB 10 billion in 2030 (vs liquid electrolyte shipments of ~5.47 million tonnes)—limited real impact before 2030; sodium-ion batteries are incremental demand, not substitution (6F lines can convert to sodium hexafluorophosphate).
4. Regulation and policy (cyclical timing analysis in Chapter XI). ① From 2026-04-01, the VAT export rebate on LiPF6 is cancelled—raises export costs and accelerates tail clearing; ② from September 2026, a 2% consumption tax on lithium batteries—raises cell costs and accelerates small-capacity clearing; ③ under the "anti-involution" policy, multiple agency industry symposiums in 2025–2026, and industry self-discipline on capacity in 6F/iron phosphate; ④ after Document No. 136 removed mandatory storage pairing, storage shifted to market-based mechanisms (capacity pricing + standalone storage), with demand rising rather than falling; ⑤ Western trade barriers (US tariffs, EU Battery Regulation + February 2028 carbon footprint rules) forcing localized capacity—positive for Tinci, which has already built US/Morocco lines, but also brings execution risk of needing to be compliant upon commissioning. Overall direction: neutral leaning positive for leaders; cost- and compliance-leading players benefit.
5. Peer comparison table:
| Company | 2025 revenue | 2026H1 revenue growth | Gross margin | ROE | Market share/rank | Key differences vs Tinci |
|---|---|---|---|---|---|---|
| Tinci Materials | RMB 16.65 billion | +109% | 33.55% (H1) | H1 half-year 15.0% | China 32.2%/global ~36% (two bases) | Deepest integration, lowest cost, greatest cyclical elasticity |
| Capchem | RMB 9.64 billion | +75.7% | 23.91% (battery chemicals 15.32%) | FY2025 10.75% | China No.3 at 13.0% | Platform type: fluorochemicals/electronic chemicals hedge the cycle with high margins; better cyclicality resistance |
| Do-Fluoride | RMB 9.43 billion | +62.6% | 6F business ~15–20% | 2026 9M cumulative 6.9% | Global No.2 in 6F (~20%, company basis) | Pure 6F elasticity play, earnings volatility far exceeding Tinci |
| Tianji Shares (ST) | RMB 2.96 billion | 2026Q1 +91% | 6F 18.12% (2025) | 2026 9M cumulative 8.0% | Top three in 6F capacity | Second-tier pure elasticity + governance risk (placed under ST in 2026-07) |
6. Company's industry position: A leader, but with share slowly declining from a high base—domestic basis 36.4% in 2023 → 32.2% in 2025 (EVTank), ~31% global basis in 2026H1 (ICC), mainly due to BYD's expanding self-supply, second-tier players ramping, and CATL order reallocation; still more than 2x the No.2 player. Moat sources: ① liquid 6F liquid-phase process (unit capex ~40% of the solid-state route, prospectus basis; broker estimates ~15–20% lower comprehensive cost)—smooths earnings in downturns and delivers the greatest elasticity in upturns; ② full-chain self-supply; ③ long-term customer contracts (CALB 101 / REPT ≥80 / Gotion 87 / SVOLT 72.5 thousand tonnes, 2026–2030); ④ overseas capacity positioning (US 200,000 t JV + Morocco 150,000 t, commissioning in 2028). Soft spots: single-customer dependence (largest customer ~42.9% in 2026H1) + a strongly cyclical profit midpoint that swings with 6F prices.
1. Cycle positioning. Lithium hexafluorophosphate (LiPF6) price cycle template (RMB 10,000/ton): 2020-07 low <7 → 2022-02 peak ~59-60 (previous supercycle, dual surge in energy storage + EV power batteries) → mid-2023 ~16 → early 2024 low ~6.3 → 2025-07-18 current cycle low 4.98 → 2025Q4 storage demand surge + low inventory, up over 120% in 4 months, spiking to ~18 in 2025-12 → falling back to 9.78 in 2026-04 → ~11.5-12 in 2026-06 → ~10.6 (SunSirs) -12.2 (TrendForce) in 2026-10. Current key metric percentiles: LiPF6 at RMB 110,000 sits at roughly the 46th percentile of the 2024-2026 cycle range (49.8k-180k) and about the 11th percentile of the 5-year range (49.8k-590k); electrolyte at ~RMB 30,000-32,000/ton sits at roughly the 14th percentile of the cycle range (17.5k-120k). Lithium carbonate futures at RMB 93,300/ton sit at roughly the 12th percentile of the 52-week range. Judgment: second year of the current upcycle, in the decelerating slope phase of price increases—prices have exited the absolute bottom but are far from the previous cycle's highs; however, the -11.3% single-month pullback in October, together with the breakdown in lithium carbonate, points to the conclusion that "this cycle's price peak (180k in 2025-12) has most likely already passed."
2. Supply response. Capacity under construction / pending release: Tinci's own 35k-ton technical upgrade has been completed and will be released "on demand" (2026H2); Tianji Phase II +15k tons began trial production on 2026-07-01; Shilei's expansion to 36k tons began ramping in early 2026 (already released); Jiangxi Fuli Phase I of 50k tons approved (commissioning date to be verified); Do-Fluoride's 20k-ton raised-capital project delayed. On the electrolyte side, 2026 nominal capacity is ~3.4 million tons vs. output of ~3 million tons—LiPF6's tight balance at 89% utilization in 2026 will face tests as supply is released in stages through 2026H2-2027; when supply overtakes demand depends on the race between storage demand growth (+40%) and actual capacity ramps (approval/certification constraints); the 2027 long-term contract negotiations (settled 2026Q4-2027Q1) are the watershed.
3. Cycle-proof earnings. Normalized (mid-cycle) earnings: net profit per ton of RMB 4,000-5,000 × full utilization of the commissioned 1.05 million tons ≈ net profit attributable to parent of RMB 4.2-5.5 billion, midpoint RMB 4.8 billion (normalized EPS ~RMB 2.35, pre-H-share dilution); trough earnings (LiPF6 at 60-70k): RMB 0.8-1.3 billion (EPS RMB 0.29-0.64; benchmarked against actual 2024 earnings of RMB 484 million × upward revision for doubled sales volume); 2026 peak EPS ~RMB 2.85-3.09 (consensus basis). Current valuation character assessment: at current prices, normalized P/E is ~11.4x—positioned below the midpoint between the "low P/E on peak earnings trap zone" and "high P/E on trough earnings": the 8.8x 2026E P/E reflects cycle-peak earnings and cannot serve as evidence of cheapness; only the 11.4x normalized P/E and the 2.70x P/B (annualized ROE ~30%, normalized ROE 15-20%) carry pricing significance. Normalized P/E ±5x sensitivity: RMB 4.8 billion × 10-15x ÷ 2.0386 billion shares (pre-dilution) = RMB 23.6-35.3; ÷ 2.4516 billion shares (fully diluted) = RMB 19.6-29.4—the conclusion is sensitive to exit multiple assumptions; if the market applies only 8-10x, the normalized valuation overlaps with the current price—this is the biggest assumption risk in this judgment. Asset-value floor: P/B 1.6-2.0x × book value per share of RMB 9.95 = RMB 15.9-19.9 (in the 2024 trough the market traded at roughly 2x P/B).
4. Downside stress test. If LiPF6 falls from the current 106-120k to 80k (-25%) → annualized attributable net profit ~RMB 2.1 billion (-56% vs. the RMB 4.8 billion midpoint); a fall to 65k (deep trough) → RMB 0.8-1.3 billion. Trough financial resilience: net interest-bearing debt of only RMB 785 million at end-2026H1, gearing ratio 36.2%, trough operating cash flow likely still positive supported by ~RMB 2 billion of D&A, plus H-share proceeds of RMB 2.8-3.6 billion moving the balance toward a net cash position of ~+RMB 2.1-2.8 billion—the company can survive a deep trough with no liquidity risk; the cost is cuts to dividends and overseas capex. Trough earnings alignment note: the previous price trough was 2025-07 (49.8k), while the earnings trough was 2024 (RMB 484 million)—the earnings trough lags the price trough; if prices bottom in 2027 this cycle, the earnings trough may come in 2027H2-2028.
5. Management's cycle discipline: partially counter-cyclical; expansion remains pro-cyclical. Counter-cyclical moves (positive): CapEx cuts at the cycle bottom in 2024-2025 (RMB 3.025 billion → 0.66-0.77 billion), consecutive dividend increases (52.15% payout ratio + special dividends), RMB 122 million of buybacks in 2025; pro-cyclical moves (negative): aggressive expansion at the 2022-2023 highs (2023 CapEx RMB 3.025 billion), and H-share-financed expansion during the 2026 upcycle (1.8 million-ton plan + overseas bases)—expansion pace moves with the cycle; if the 2027 oversupply materializes, industry-wide expansion (including the company's own 35k-ton upgrade release) will deepen the cycle bottom.
Overall verdict: Cautiously bullish (confidence 0.58, 12 months). Tinci is one of the highest-quality assets in a cyclical industry (left side of the cost curve + full utilization + long-term contract volume lock-ins + low leverage); the current price of RMB 26.89 already fully prices in the LiPF6 cycle downturn (implied normalized earnings of RMB 3.7-4.6 billion < annualized single-quarter RMB 4.8 billion), while storage volume growth is essentially unpaid for; however, the LiPF6 price peak has passed, 2027 supply release is a base-case event, and the H-share issuance and RMB 10.7 billion of receivables are near-term overhangs. Strategically, this is a left-side, odds-driven opportunity rather than a right-side trend: the current price offers a base-case downside margin of safety of +11.6% and a scenario odds structure of roughly 3:1 (base-case midpoint +33.9% / bear-case midpoint -36.8% / bull-case midpoint +126.9%), but realization depends on three event confirmations, and position sizing should be staged in line with event confirmation.
Risks and catalysts (tracking calendar for the next 6-12 months):
Key falsification conditions: LiPF6 weekly average price falling below RMB 90,000/ton; Q3 attributable net profit below RMB 1.3 billion (QoQ decline); deep H-share discount (>15%) or full-cap issuance; long-term contract customers taking delivery significantly below plan; deterioration in receivables aging (1+ year share >5%). Any of the above triggers should prompt a re-assessment of normalized earnings and the scenario range.